title: Cytokine-release syndrome related to rituximab limited to lesions and excision scars of lesions of primary cutaneous lymphoma.
authors.forename: Silvia
authors.initials: S
authors.lastname: Perez-Gala
authors.forename: Yolanda
authors.initials: Y
authors.lastname: Delgado-Jimenez
authors.forename: Rebeca
authors.initials: R
authors.lastname: Goiriz
authors.forename: Javier
authors.initials: J
authors.lastname: Fraga
authors.forename: Amaro
authors.initials: A
authors.lastname: Garcia-Diez
authors.forename: Jesus
authors.initials: J
authors.lastname: Fernandez-Herrera
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents / Q000009:adverse effects*; D002921:Cicatrix / Q000473:pathology; D016207:Cytokines / Q000378:metabolism*; D003937:Diagnosis, Differential; D006801:Humans; D016393:Lymphoma, B-Cell / Q000188:drug therapy*; D008297:Male; D000069283:Rituximab; D012878:Skin Neoplasms / Q000188:drug therapy*; D013577:Syndrome
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D016207:Cytokines; D000069283:Rituximab